Eight innovation projects are to share funding of more than £9 million, as part of a cancer innovation programme.
SBRI Healthcare, in partnership with the NHS Cancer Programme and the Accelerated Access Collaborative, announced the eight late stage innovation projects that support earlier diagnosis, coordination, communication, scanning and imaging, medical devices, blood testing and administrative tasks.
The funding competition launched in March 2021, attracting 51 applications as part of the first phase, with phase two now open for applications.
The competition winners included:
- Qure.ai Technologies Limited (awarded £3,221,710) – AI assisted Chest X-ray triage for improving diagnostic efficiency and early detection of lung cancer
- The Royal Marsden NHS Foundation Trust (awarded £610,774) – Whole body MRI for Inherited Cancer Early Diagnosis (ICED)
- Open Medical (awarded £ 1,063,081) – Pathpoint Cancer Initiative – Scaling and evaluating interoperable cloud clinical pathway management solutions to optimise referral, triage and diagnostic workflows
- Endoscope-i (awarded £424,418) – Telescopic referrals to streamline and increase efficiency for managing the Head and Neck 2ww cancer pathway
- Pinpoint Data Science (awarded £752,021) – Optimising NHS urgent cancer referral pathways with their AI-driven, affordable blood test for triage and prioritisation of symptomatic patients
- The Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University (awarded £1,624,825 ) – Dissemination of the Newcastle MSI-PLUS assay for Lynch syndrome screening and therapeutic targeting
- Orion Medtech Ltd C.I.C (awarded £361,487) – Applying a cancer care toolkit for improving time from diagnosis to treatment by adapting existing digital technology and processes
- The Royal Marsden NHS Foundation Trust (awarded £1,237,838) – Liquid Biopsies for Faster Diagnosis of Pancreatic and Biliary Tract Cancers